The conserved nsp1-binding site on the 40S ribosome along with the reduced nsp1 genetic drift among SARS-CoV-2 variants87, relative to the spike glycoprotein, suggest the possibility of targeting this key virulence factor to develop next-generation COVID-19 countermeasures. The gene discussed is SH2D3A; the disease is COVID-19.